Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice

Bone

Volumn 20, Issue 4, 1997, Pages 335-340

  Van Beek, Ermond R ^a   Lowik C W G M ^a   Papapoulos, S E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alendronate; Bisphosphonates; Bone resorption; Macrophage precursors; Mouse bone marrow; Osteoclast formation

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; GRANULOCYTE PRECURSOR; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ALENDRONATE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; BONE MARROW; BONE MARROW CELLS; BONE RESORPTION; CALCIUM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION; INJECTIONS, SUBCUTANEOUS; MACROPHAGES; METATARSAL BONES; MICE; MONOCYTES; ORGAN CULTURE TECHNIQUES; OSTEOCLASTS; STEM CELLS; TIBIA;

EID: 0342981654     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00006-9     Document Type: Article

References (32)

1. Alterman, A., Crispe, N., and Kinnon, C. Characterization of the murine heat-stable antigen: An hematolymphoid differentiation antigen defined by J11d, M1/69 and B2A2 antibodies. Eur J Immunol 20:1597-1602; 1990.
2. Boonekamp, P. M., van der Wee-Pals, L. J. A., van Wijk-van Lennep, M. M. L., Tesingh, C. W., and Bijvoet, O. L. M. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1:27-39; 1986.
3. Bruijn, M. F. T. R., Slieker, W. A. T., van der Loo, J. C. M., Voerman, J. S. A., van Ewijk, W., and Leenen, P. J. M. Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24:2279-2284; 1994.
4. Burger, E. H., van der Meer, J. W. M., van de Gevel, J. S., Gribnau, J. C., Thesingh, C. W., and van Furth, R. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156: 1604-1615; 1982.
5. Cecchini, M. G., Felix, R., Fleisch, H., and Cooper, P. H. Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J Bone Miner Res 2:135-142; 1987.
6. Cecchini, M. G. and Fleisch, H. Bisphosphonates in vitro specifically inhibit, among the haematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 5:1019-1027; 1990.
7. Cooper, P. H., Mayer, P., and Baggiolini, M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: Correlation with biochemical and functional parameters. J Immunol 133:913-921; 1984.
8. Endo, Y., Nakamura, M., Kikuchi, T., Shinoda, H., Takeda, Y., Nitta, Y., and Kumagai, K. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes. and osteoclasts in vivo. Calcif Tissue Int 52:248-254; 1993.
9. Falla, N., van Vlasselaer, P., Bierkens, J., Borremans, B., Schoeters, G., and van Gorp, U. Characterization of 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 82:3580-3585; 1993.
10. Fleisch, H. Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemic and metastatic bone disease. Drugs 42:919-944; 1991.
11. Geddes, A. D., D'Souza, S. M., Ebetino, F. H., and Ibbotson, K. J. Bisphosphonates: Structure-activity relationships and therapeutic implications. In: Heersche, J. N. M. and Kanis, J. A., Eds. Bone and mineral research. Vol. 8. Amsterdam: Elsevier Science BV; 1994; 265-306.
12. Hughes, D. E., MacDonald, B. R., Russel, G. G., and Gowen, M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930-1935; 1989.
13. Leenen, P. J. M., de Bruijn, M. F. T. R., Voerman, J. S. A., Campbell, P. A., and van Ewijk, W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174:5-19; 1994.
14. Leenen, P. J. M., Kroos, M. J., Melis, M., Slieker, W. A. T., van Ewijk, W., and van Ewijk, H. G. Differential inhibition of macrophage proliferation by anti-transferrin receptor antibody ER-MP21: Correlation to macrophage differentiation stage. Exp Cell Res 189:55-63; 1990.
15. Leenen, P. J. M., Melis, M., Slieker, W. A. T., and van Ewijk, W. Murine macrophage precursors characterization II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 20:27-34; 1990.
16. Lin, J. H. Bisphosphonates: A review of their pharmacokinetic properties. Bone 18:75-85; 1996.
17. Löwik, C. and Van der Pluim, G. Mechanisms of action of bisphosphonates: Studies with bone culture systems. In: Bijvoet, O. L. M., Fleisch, H. A., Canfield, R. E., and Russel, R. G. G., Eds. Bisphosphonate on bones. Amsterdam: Elsevier Science BV; 1995; 231-245.
18. 3H-etidronate in rat and mouse bones. Bone 19:281-290; 1996.
19. Most, W., Schot L., Ederveen, A., van der Wee-Pals, L., Papapoulos, S., and Löwik, C. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. J Bone Miner Res 10:1523-1530; 1995.
20. Most, W., van der Wee-Pals, L., Ederveen, A., Papapoulos, S., and Löwik, C. Ovariectomy and orchidectomy induce transient increase in the osteoclastogenic potential of the bone marrow cells in mice. Bone 20:27-30; 1997.
21. Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., and Suda, T. A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17:137-144; 1995.
22. Nishikawa, M., Akatsu, T., Katayama Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., and Nagata, N. Bisphosphonates act on osteblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18:9-14; 1996.
23. Papapoulos, S. E. Pharmacodynamics of bisphosphonates in man: Implications for treatment. In: Bijvoet, O. L. M., Fleisch, H. A., Canfield, R. E., and Russel, R. G. G., Eds. Bisphosphonate on bones. Amsterdam: Elsevier Science BV; 1995; 231-245.
24. Papapoulos, S. E. Bisphosphonates: Pharmacology and the use in the treatment of osteoporosis. In: Marcus, R., Feldman, D., and Kelsey, J., Eds. Osteoporosis. San Diego: Academic; 1996; 1209-1234.
25. Rodan, A. and Fleisch, H. A. Bisphosphonates: Mechanism of action. J Clin Invest 97:2692-2696; 1996.
26. Sauty, A., Pecherstorfer, M., Zimmer-Roth, I., Fioroni, P., Juillerat, L., Markert, M., Ludwig, P., Leuenberger, P., Burckhardt, P., and Thiebaud, D. Interleukin-6 and tumor necrosis factor-α levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 18:133-139; 1996.
27. Scheven, B., Kawilarang-de Haas, E., Wassenaar, A., and Nijwijde, P. Differentiation kinetics of osteoclasts in the periosteum of embryonic long bones in vivo and in vitro. Anat Rec 214:418-423.
28. Schweitzer, D. H., Oostendorp-van de Ruit, M., van der Pluijm, G., Löwik, C., and Papapoulos, S. E. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 10:956-962; 1995.
29. Shani, M., Guenther, H. L., Fleisch, H., Collin, P., and Martin, T. J. Bisphosphonates act on rat bone through the mediation of osteoblasts. J Clin Invest 91:2004-2011; 1993.
30. Van der Pluijm, G., Löwik, C., de Groot, H., Alblas, M. J., van der Wee-Pals, L. J. A., Bijvoet, O. L. M., and Papapoulos, S. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. J Bone Miner Res 1203-1210; 1991.
31. Van der Pluijm, G.. Most, W., van der Wee-Pals, L., de Groot, H., Papapoulos, S., and Löwik, C. Two distinct effects of recombinant human tumor necrosis factor-α on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology 129:1596-1604; 1991.
32. Vitté, C., Fleisch, H., and Guenther, L. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 137: 2324-2333; 1996.